Reported Consolidated quarterly numbers for Bliss GVS Pharma are: Net Sales at Rs 198.13 crore in March 2024 up 7.22% from Rs. 184.78 crore in March 2023. Quarterly Net Loss at Rs. 9.15 crore in March 2024 down 373.57% from Rs. 3.34 crore in March 2023. EBITDA stands at Rs. 33.95 crore in March 2024 up 268.62% from Rs. 9.21 crore in March 2023.
Open FlipREC Q4 Results: REC, the company, announced its Q4 results on 30th April 2024, showcasing a significant growth in both revenue and profit compared to the previous year. The topline of REC increased by 22.06% Year-on-Year, while the profit surged by 33.07% Year-on-Year. Additionally, in comparison to the previous quarter, the revenue saw a growth of 3.93%.
Open FlipReported Consolidated quarterly numbers for Skipper are: Net Sales at Rs 1,153.51 crore in March 2024 up 75.48% from Rs. 657.36 crore in March 2023. Quarterly Net Profit at Rs. 25.16 crore in March 2024 up 6.09% from Rs. 23.72 crore in March 2023. EBITDA stands at Rs. 111.54 crore in March 2024 up 52.02% from Rs. 73.37 crore in March 2023. Skipper EPS has increased to Rs. 2.37 in March 2024.
Open Flip